Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 14 |
NetGPI | no | yes: 0, no: 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q0W4
Term | Name | Level | Count |
---|---|---|---|
GO:0003352 | regulation of cilium movement | 6 | 15 |
GO:0032886 | regulation of microtubule-based process | 4 | 15 |
GO:0050789 | regulation of biological process | 2 | 15 |
GO:0050794 | regulation of cellular process | 3 | 15 |
GO:0060632 | regulation of microtubule-based movement | 5 | 15 |
GO:0065007 | biological regulation | 1 | 15 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 119 | 123 | PF00656 | 0.422 |
CLV_C14_Caspase3-7 | 33 | 37 | PF00656 | 0.470 |
CLV_C14_Caspase3-7 | 97 | 101 | PF00656 | 0.418 |
CLV_NRD_NRD_1 | 223 | 225 | PF00675 | 0.283 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.539 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.377 |
CLV_PCSK_KEX2_1 | 90 | 92 | PF00082 | 0.511 |
CLV_PCSK_PC1ET2_1 | 7 | 9 | PF00082 | 0.377 |
DEG_APCC_DBOX_1 | 44 | 52 | PF00400 | 0.430 |
DOC_CYCLIN_RxL_1 | 78 | 89 | PF00134 | 0.498 |
DOC_MAPK_gen_1 | 186 | 196 | PF00069 | 0.455 |
DOC_MAPK_gen_1 | 87 | 95 | PF00069 | 0.473 |
DOC_MAPK_MEF2A_6 | 189 | 196 | PF00069 | 0.454 |
DOC_PP1_RVXF_1 | 162 | 169 | PF00149 | 0.534 |
DOC_PP1_RVXF_1 | 45 | 51 | PF00149 | 0.366 |
DOC_USP7_MATH_1 | 116 | 120 | PF00917 | 0.448 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.555 |
DOC_USP7_MATH_2 | 10 | 16 | PF00917 | 0.554 |
DOC_USP7_UBL2_3 | 182 | 186 | PF12436 | 0.457 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.450 |
DOC_USP7_UBL2_3 | 56 | 60 | PF12436 | 0.412 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.414 |
LIG_14-3-3_CanoR_1 | 146 | 151 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 45 | 51 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 81 | 86 | PF00244 | 0.513 |
LIG_CaM_IQ_9 | 216 | 232 | PF13499 | 0.552 |
LIG_EH1_1 | 144 | 152 | PF00400 | 0.485 |
LIG_FHA_1 | 191 | 197 | PF00498 | 0.470 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.497 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.386 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.454 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.508 |
LIG_LIR_Apic_2 | 243 | 248 | PF02991 | 0.470 |
LIG_LIR_Gen_1 | 15 | 26 | PF02991 | 0.393 |
LIG_LIR_Gen_1 | 79 | 89 | PF02991 | 0.428 |
LIG_LIR_Nem_3 | 15 | 21 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.410 |
LIG_PCNA_PIPBox_1 | 215 | 224 | PF02747 | 0.459 |
LIG_PCNA_yPIPBox_3 | 224 | 233 | PF02747 | 0.505 |
LIG_PCNA_yPIPBox_3 | 90 | 103 | PF02747 | 0.449 |
LIG_SH2_STAP1 | 14 | 18 | PF00017 | 0.457 |
LIG_SH2_STAT3 | 223 | 226 | PF00017 | 0.523 |
LIG_SH2_STAT5 | 183 | 186 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.532 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.456 |
LIG_SH3_3 | 199 | 205 | PF00018 | 0.455 |
LIG_TRAF2_1 | 10 | 13 | PF00917 | 0.544 |
LIG_WW_3 | 203 | 207 | PF00397 | 0.459 |
MOD_CK2_1 | 134 | 140 | PF00069 | 0.470 |
MOD_GlcNHglycan | 117 | 121 | PF01048 | 0.414 |
MOD_GlcNHglycan | 161 | 164 | PF01048 | 0.484 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.243 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.264 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.541 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.526 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.410 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.453 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.536 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.460 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.359 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.532 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.385 |
MOD_NEK2_2 | 257 | 262 | PF00069 | 0.489 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.467 |
MOD_PKA_2 | 46 | 52 | PF00069 | 0.406 |
MOD_Plk_1 | 157 | 163 | PF00069 | 0.414 |
MOD_Plk_1 | 236 | 242 | PF00069 | 0.466 |
MOD_Plk_2-3 | 134 | 140 | PF00069 | 0.469 |
MOD_Plk_4 | 146 | 152 | PF00069 | 0.391 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.500 |
MOD_SUMO_for_1 | 10 | 13 | PF00179 | 0.470 |
MOD_SUMO_rev_2 | 207 | 214 | PF00179 | 0.459 |
MOD_SUMO_rev_2 | 227 | 232 | PF00179 | 0.449 |
TRG_DiLeu_BaEn_1 | 228 | 233 | PF01217 | 0.517 |
TRG_DiLeu_BaEn_1 | 98 | 103 | PF01217 | 0.426 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 82 | 85 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 45 | 48 | PF00400 | 0.354 |
TRG_Pf-PMV_PEXEL_1 | 230 | 234 | PF00026 | 0.288 |
TRG_Pf-PMV_PEXEL_1 | 81 | 86 | PF00026 | 0.471 |
TRG_Pf-PMV_PEXEL_1 | 91 | 96 | PF00026 | 0.497 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKY2 | Leptomonas seymouri | 84% | 100% |
A0A0S4JE13 | Bodo saltans | 26% | 92% |
A0A0S4JRV9 | Bodo saltans | 56% | 100% |
A0A1X0P0N8 | Trypanosomatidae | 65% | 100% |
A0A3Q8IRH9 | Leishmania donovani | 97% | 100% |
A0A3R7NWF2 | Trypanosoma rangeli | 66% | 100% |
A4HPL6 | Leishmania braziliensis | 25% | 79% |
A4HPW7 | Leishmania braziliensis | 95% | 100% |
A4IDM9 | Leishmania infantum | 97% | 100% |
D0A4B5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 100% |
E9ATN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
V5B520 | Trypanosoma cruzi | 68% | 100% |
V5B6Z0 | Trypanosoma cruzi | 24% | 94% |